Eli Lilly And Company
Found 1 recent publications
Today, Nov 17
06:46

Health
Five-Year Data Confirms Leqembi Effectively Slows Early Alzheimer's Progression
New five-year data presented at the CTAD conference show that the Alzheimer's drug Leqembi keeps 70% of patients in early disease stages, reducing advanced dementia risk by 50% and delaying cognitive decline.
Showing latest 50 articles for this tag